Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
MET Biologics Sequence Review Report 2026: Hepatocyte growth factor receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MET protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRL2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of ADGRL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRL1 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of ADGRL1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
NGF Biologics Sequence Review Report 2026: Beta-nerve growth factor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of NGF protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ADGRB3 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor B3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of ADGRB3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PTPRZ1 Biologics Sequence Review Report 2026: Receptor-type tyrosine-protein phosphatase zeta Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTPRZ1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TGFA Biologics Sequence Review Report 2026: Protransforming growth factor alpha Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TGFA protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TFRC Biologics Sequence Review Report 2026: Transferrin receptor protein 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TFRC protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CR2 Biologics Sequence Review Report 2026: Complement receptor type 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LY86 Biologics Sequence Review Report 2026: Lymphocyte antigen 86 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LY86 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LIFR Biologics Sequence Review Report 2026: Leukemia inhibitory factor receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of LIFR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CNTFR Biologics Sequence Review Report 2026: Ciliary neurotrophic factor receptor subunit alpha Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CNTFR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
14
15
16
17
18
>>
1103
>